Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms 99mTc-HMPAO, Kit for the Preparation of Exametazime Technetium(99mTc) Injection, エキサメタジム + [5] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (31 Mar 1989), |
Regulation- |
Molecular FormulaC13H25N4O3Tc |
InChIKeyPEKLPTLOROUODP-NGAFWABFSA-N |
CAS Registry100504-35-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Technetium tc-99m exametazime |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Inflammatory Bowel Diseases | United States | 05 Aug 2013 | |
Intraabdominal Infections | United States | 05 Aug 2013 | |
Stroke | United States | 05 Aug 2013 | |
Cerebrovascular Disorders | Japan | 31 Mar 1989 |
Not Applicable | - | - | (Plasma group) | nddzfkslsc(avvpswmuzq) = hpgcovceje taihtwdqid (rtnfttkqfx, 3.82) View more | Positive | 18 Sep 2018 | |
(Saline group) | nddzfkslsc(avvpswmuzq) = mwnjulvibo taihtwdqid (rtnfttkqfx, 3.48) View more | ||||||
Not Applicable | - | 99mTc-HMPAOO-labeled leukocyte (99mTc-HMPAO labeled leukocytes) | (csljgzaxjk) = whxzwdfjph kmhrjnpopj (yokxxdigcc ) View more | - | 23 May 2018 |